Leading global clinical trial supply companies 2024: Reliable commercial drug sourcing and supply for clinical research, with a truly global approach. ClientPharma is perfectly equipped to ensure fast, accurate and reliable pharmaceutical supply. With unparalleled service and unmatched access, ClientPharma sources and supplies commercial drug product for global clinical trials. From provision of clinical research samples, to bulk supplies for your pivotal trials, we have the network and know-how to provide strategic sourcing solutions at every stage of clinical research. Find additional details at biosimilars and reference medicines.
ClientPharma is licensed and follows regulatory directives and guidelines, complying with Good Distribution Practice (GDP) for Medicines for Human Use, 2013/C 343/01. Our Quality Department is responsible for vigorously maintaining the quality and integrity of your products through our comprehensive Quality Management System. Continuous focus and commitment to quality assures compliance across the board — for the client, for the regulatory agencies, and most importantly, for the patient.
Unbeatable global access to commercial drug products – Unlike many comparator drug sourcing companies, our ethos is to challenge the norms and adapt to your specific needs. We understand the complexities and challenges of multi-faceted projects with time and temperature specifics. Using a combined understanding of your clinical requisites and our extensive knowledge of the commercial market landscape, we work to design a supply strategy unique to your needs. Ask our team for a customized product supply assessment.
We are dedicated to delivering on point and on time, every time, no matter how technically challenging. With our preferred logistics partners, we offer warehousing solutions and specialist logistics to meet your clinical trial requirements. Global pharma warehousing and distribution capabilities: With our own state-of-the-art pharmaceutical warehouses strategically situated in major European and North American distribution hubs, as well as our global network of partner depots, ClientPharma provides you with your clinical trial supplies precisely where and when you need them. With access to our secure pharmaceutical warehousing, you can be confident in the integrity of your supply chain. All of our high-security storage conforms to strict cGDP guidelines. See more information at https://www.clientpharma.com/.
Andrea Chopek, President, North America at ClientPharma relayed, “Our industry is yearning for a sleek, global approach for commercial drug supply — and with this strategic partnership, we offer that. Together, we solve drug supply difficulties and navigate the many complexities — reducing supply chain risks and managing waste and costs throughout the stages of your clinical trial. Two industry leaders coming together doesn’t dilute the solution, it provides one concentrated, easy solution for our clients.” TrialCard Incorporated is a full-service life sciences commercialization partner that provides comprehensive solutions that span the entire biopharmaceutical value chain. In addition to a foundation of fully integrated, digitally enabled patient support services, its broader offerings include everything from late-stage clinical trial management to post-marketing HCP engagement services and proprietary data-as-a-service payer intelligence and insights. Founded in 2000, TrialCard provides commercialization needs for more than 160 life science customers and has connected over 35 million patients with more than $18 billion in branded drug savings to date. The company is headquartered in Morrisville, North Carolina.
Forecasts by their very definition involve a degree of uncertainty. When a company fails to meet demand it can have major implications on the drug and the pharmaceutical company. The company may experience loss in sales, a bad reputation for unreliability with customers and overworked employees. It has been reported that where the drug itself is concerned, if the launch of a medicine is delayed due to a failure in estimation, it costs on average $15 million per drug, per day. Further research has also shown that a blockbuster drug will lose $1 billion in revenue annually until capacity is developed to meet demand. Overestimations in demand generally happen when the market is at its most volatile, or, if the reach of a new drug has been over estimated. These inaccuracies can cost companies. If a product’s demand is overestimated, companies have to find ways to correct their misjudgement by cutting the price of medicines which reduces margins and by making employees redundant to pay for the excess of stock. In some cases companies also have to destroy stock that has not been sold.